Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

33.80
-0.0866-0.26%
Post-market: 33.820.0214+0.06%19:30 EDT
Volume:18.43K
Turnover:624.68K
Market Cap:32.11M
PE:- -
High:33.96
Open:33.90
Low:33.80
Close:33.89
52wk High:36.72
52wk Low:25.59
Shares:950.00K
Float Shares:950.00K
Volume Ratio:4.61
T/O Rate:1.94%
Dividend:0.16
Dividend Rate:0.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

UnitedHealth (UNH) Gets a Buy from Bernstein

TIPRANKS
·
Sep 04

BOB Capital Markets Cuts Abbott India PT on Slower Sales Growth Outlook

Reuters
·
Sep 04

Abbott VP, Controller John A. McCoy Jr Disposes of Common Shares Worth $8,685.45

Reuters
·
Sep 04

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

Steris PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 04

Abbott Laboratories Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 04

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
Sep 04

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Sep 03

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Sep 03

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Sep 03

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Sep 03

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Sep 03

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02